LianBio (LIANY)
OTCMKTS · Delayed Price · Currency is USD
0.1106
0.00 (0.00%)
At close: Jul 6, 2026
LianBio Market Cap
LianBio has a market cap or net worth of $11.96 million as of July 8, 2026. Its market cap has decreased by -44.70% in one year.
Market Cap
11.96M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.11
Market Cap Chart
Since November 1, 2021, LianBio's market cap has decreased from 1.44B to 11.96M, a decrease of -99.17%. That is a compound annual growth rate of -64.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 11.96M | 16.42% |
| Dec 31, 2025 | 10.28M | -64.15% |
| Dec 31, 2024 | 28.66M | -94.07% |
| Dec 29, 2023 | 483.04M | 171.83% |
| Dec 30, 2022 | 177.70M | -73.10% |
| Dec 31, 2021 | 660.59M | -54.19% |
| Nov 1, 2021 | 1.44B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Finch Therapeutics Group | 16.86M |
| Zenith Capital | 15.97M |
| Brainstorm Cell Therapeutics | 15.89M |
| Anebulo Pharmaceuticals | 15.50M |
| Zeo ScientifiX | 14.89M |
| Galera Therapeutics | 14.68M |
| Inhibitor Therapeutics | 13.75M |
| Nymox Pharmaceutical | 12.24M |